HUP0105391A2 - Immunogén lipószómakészítmények - Google Patents
Immunogén lipószómakészítményekInfo
- Publication number
- HUP0105391A2 HUP0105391A2 HU0105391A HUP0105391A HUP0105391A2 HU P0105391 A2 HUP0105391 A2 HU P0105391A2 HU 0105391 A HU0105391 A HU 0105391A HU P0105391 A HUP0105391 A HU P0105391A HU P0105391 A2 HUP0105391 A2 HU P0105391A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- liposome compositions
- immunogenic liposome
- immunogenic
- antigenic
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 2
- 239000002502 liposome Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
A találmány tárgya egy immunogén liposzómakészítmény, melyvezikulumképző lipideket valamint egy vagy több antigéndeterminánst ésegy hidrofób domént tartalmazó antigénszerkezetet tartalmaz. Akészítmény egy vagy több adjuvánst is tartalmazhat. A találmánytovábbá a fenti készítmény előállítási eljárásaira, valamint aliposzómakészítményt tartalmazó vakcinákra is vonatkozik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10135198P | 1998-09-22 | 1998-09-22 | |
US40072399A | 1999-09-21 | 1999-09-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0105391A2 true HUP0105391A2 (hu) | 2002-05-29 |
HUP0105391A3 HUP0105391A3 (en) | 2006-02-28 |
Family
ID=26798150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0105391A HUP0105391A3 (en) | 1998-09-22 | 1999-09-22 | Immunogenic liposome compositions |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1115382B1 (hu) |
JP (1) | JP2002526436A (hu) |
KR (1) | KR100592825B1 (hu) |
CN (1) | CN1555254A (hu) |
AP (1) | AP2010A (hu) |
AT (1) | ATE468108T1 (hu) |
AU (1) | AU766772B2 (hu) |
BG (1) | BG65675B1 (hu) |
BR (1) | BR9914004A (hu) |
CA (1) | CA2344173C (hu) |
CY (1) | CY1110718T1 (hu) |
CZ (1) | CZ20011013A3 (hu) |
DE (1) | DE69942393D1 (hu) |
DK (1) | DK1115382T3 (hu) |
EA (1) | EA004797B1 (hu) |
EE (1) | EE200100168A (hu) |
ES (1) | ES2345695T3 (hu) |
GE (1) | GEP20053444B (hu) |
HK (1) | HK1039064A1 (hu) |
HU (1) | HUP0105391A3 (hu) |
ID (1) | ID29082A (hu) |
IL (2) | IL141675A0 (hu) |
MX (1) | MXPA01002973A (hu) |
NO (1) | NO330685B1 (hu) |
NZ (2) | NZ528055A (hu) |
OA (1) | OA11657A (hu) |
PL (1) | PL206260B1 (hu) |
SK (1) | SK287670B6 (hu) |
UA (1) | UA75327C2 (hu) |
WO (1) | WO2000016746A2 (hu) |
ZA (1) | ZA200101829B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200726479A (en) | 2005-04-12 | 2007-07-16 | Univ Duke | Method of inducing neutralizing antibodies to human immunodeficiency virus |
CA2764424C (en) | 2009-06-04 | 2019-12-31 | National Institute Of Advanced Industrial Science And Technology | Vaccine for mycoplasma infection |
EA034702B1 (ru) | 2011-04-26 | 2020-03-10 | Молекулар Экспресс, Инк. | Липосомные композиции |
US10076567B2 (en) | 2013-09-27 | 2018-09-18 | Duke University | MPER-liposome conjugates and uses thereof |
AU2018250226A1 (en) * | 2017-04-04 | 2019-10-10 | Barinthus Biotherapeutics North America, Inc. | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response |
KR20240033309A (ko) * | 2022-09-05 | 2024-03-12 | 주식회사 차백신연구소 | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
SE462375B (sv) * | 1985-10-15 | 1990-06-18 | Morgaardshammar Ab Centro | Traadblock |
DE3776966D1 (de) | 1986-05-20 | 1992-04-09 | Wako Pure Chem Ind Ltd | Funktionelle gruppen tragende liposome und verfahren zu deren herstellung. |
FR2754543B1 (fr) | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
-
1999
- 1999-09-02 ID IDW20010900A patent/ID29082A/id unknown
- 1999-09-22 UA UA2001031606A patent/UA75327C2/uk unknown
- 1999-09-22 DK DK99969329.4T patent/DK1115382T3/da active
- 1999-09-22 HU HU0105391A patent/HUP0105391A3/hu unknown
- 1999-09-22 NZ NZ528055A patent/NZ528055A/en not_active IP Right Cessation
- 1999-09-22 KR KR1020017003621A patent/KR100592825B1/ko not_active IP Right Cessation
- 1999-09-22 PL PL348604A patent/PL206260B1/pl not_active IP Right Cessation
- 1999-09-22 CA CA2344173A patent/CA2344173C/en not_active Expired - Fee Related
- 1999-09-22 AP APAP/P/2001/002096A patent/AP2010A/en active
- 1999-09-22 ES ES99969329T patent/ES2345695T3/es not_active Expired - Lifetime
- 1999-09-22 MX MXPA01002973A patent/MXPA01002973A/es not_active IP Right Cessation
- 1999-09-22 WO PCT/US1999/020880 patent/WO2000016746A2/en active IP Right Grant
- 1999-09-22 AU AU60351/99A patent/AU766772B2/en not_active Ceased
- 1999-09-22 BR BR9914004-7A patent/BR9914004A/pt not_active IP Right Cessation
- 1999-09-22 NZ NZ510442A patent/NZ510442A/en not_active IP Right Cessation
- 1999-09-22 OA OA1200100075A patent/OA11657A/en unknown
- 1999-09-22 GE GE4350A patent/GEP20053444B/en unknown
- 1999-09-22 AT AT99969329T patent/ATE468108T1/de active
- 1999-09-22 CZ CZ20011013A patent/CZ20011013A3/cs unknown
- 1999-09-22 EA EA200100269A patent/EA004797B1/ru not_active IP Right Cessation
- 1999-09-22 IL IL14167599A patent/IL141675A0/xx active IP Right Revival
- 1999-09-22 CN CNA99811216XA patent/CN1555254A/zh active Pending
- 1999-09-22 SK SK322-2001A patent/SK287670B6/sk not_active IP Right Cessation
- 1999-09-22 JP JP2000573707A patent/JP2002526436A/ja active Pending
- 1999-09-22 EE EEP200100168A patent/EE200100168A/xx unknown
- 1999-09-22 EP EP99969329A patent/EP1115382B1/en not_active Expired - Lifetime
- 1999-09-22 DE DE69942393T patent/DE69942393D1/de not_active Expired - Lifetime
-
2001
- 2001-02-27 IL IL141675A patent/IL141675A/en not_active IP Right Cessation
- 2001-03-05 ZA ZA200101829A patent/ZA200101829B/en unknown
- 2001-03-20 NO NO20011406A patent/NO330685B1/no not_active IP Right Cessation
- 2001-03-22 BG BG105372A patent/BG65675B1/bg unknown
-
2002
- 2002-01-17 HK HK02100385.1A patent/HK1039064A1/xx not_active IP Right Cessation
-
2010
- 2010-07-30 CY CY20101100715T patent/CY1110718T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203817A2 (hu) | Polioxietilén-alkil-étert vagy -észtert és legalább egy nemionos felületaktív anyagot tartalmazó adjuváns | |
ATE227134T1 (de) | Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen | |
WO2002009746A8 (en) | Vaccines comprising outer membrane vesciles from gram negative bacteria | |
HUP0101323A1 (hu) | Vakcinakészítmények | |
HUP0101619A2 (hu) | Adjuvánskészítmények | |
GB0123580D0 (en) | Vaccine | |
PT1104306E (pt) | Composicoes de cpg e adjuvantes de saponina e seus metodos | |
HUP0402067A2 (hu) | Oltóanyagok | |
DE60136650D1 (de) | Kosmetische zusammensetzung enthaltend vernetzte silikonelastomere | |
ATE419873T1 (de) | Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs | |
EP1433464A3 (en) | Hair cleansing composition | |
BR9506885A (pt) | Vacinas contendo vesículas de lipidio paucilamelares como adjuvantes imunológicos | |
WO2002096936A3 (en) | Daptomycin and related analogs in crystalline form, their preparation and use | |
DE69714011D1 (de) | Die erzeugung einer immunantwort gegen erwünschte determinanten | |
DK0973544T3 (da) | Immuntolerant prothrombinkomplekspræparat | |
AU2001263245A1 (en) | Preparation of hydroxyalkylcarbamates from six-membered cyclic carbonates | |
HUP0105391A2 (hu) | Immunogén lipószómakészítmények | |
FI972054A0 (fi) | Immunogeenisiä koostumuksia | |
HUP9701586A2 (hu) | Javított inaktivált vakcinák | |
WO2001070265A3 (en) | Lipopeptide adjuvants | |
EP0983086A4 (en) | PH-SENSITIVE LIPOSOMES AND OTHER TYPES OF IMMUNOMODULATORS CONTAINING ENCLOSED VACCINE AND PRODUCTION AND USE METHOD THEREFOR | |
ATE329615T1 (de) | Borrelia burgdorferi bacterin | |
PL348550A1 (en) | Ibdv mutant, vaccine containing it for protecting poultry against a disease caused by ibdv and method of protecting poultry against such disease | |
WO2002024147A3 (en) | Avian pneumovirus vaccine | |
AU2003281909A1 (en) | Method of obtaining conjugate vaccines and vaccine compositions containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |